110 related articles for article (PubMed ID: 31437074)
1. Recombinant protein CCN5/WISP2 promotes islet cell proliferation and survival
Kaddour N; Zhang D; Gao ZH; Liu JL
Growth Factors; 2019 Aug; 37(3-4):120-130. PubMed ID: 31437074
[TBL] [Abstract][Full Text] [Related]
2. IGF-I stimulates CCN5/WISP2 gene expression in pancreatic β-cells, which promotes cell proliferation and survival against streptozotocin.
Chowdhury S; Wang X; Srikant CB; Li Q; Fu M; Gong YJ; Ning G; Liu JL
Endocrinology; 2014 May; 155(5):1629-42. PubMed ID: 24552398
[TBL] [Abstract][Full Text] [Related]
3. Role of CCN5 (WNT1 inducible signaling pathway protein 2) in pancreatic islets.
Liu JL; Kaddour N; Chowdhury S; Li Q; Gao ZH
J Diabetes; 2017 May; 9(5):462-474. PubMed ID: 27863006
[TBL] [Abstract][Full Text] [Related]
4. Degradomic and yeast 2-hybrid inactive catalytic domain substrate trapping identifies new membrane-type 1 matrix metalloproteinase (MMP14) substrates: CCN3 (Nov) and CCN5 (WISP2).
Butler GS; Connor AR; Sounni NE; Eckhard U; Morrison CJ; Noël A; Overall CM
Matrix Biol; 2017 May; 59():23-38. PubMed ID: 27471094
[TBL] [Abstract][Full Text] [Related]
5. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
Zhang L; Li Y; Liang C; Yang W
Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
[TBL] [Abstract][Full Text] [Related]
6. CCN2 and CCN5 exerts opposing effect on fibroblast proliferation and transdifferentiation induced by TGF-β.
Xu H; Li P; Liu M; Liu C; Sun Z; Guo X; Zhang Y
Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1207-19. PubMed ID: 26218313
[TBL] [Abstract][Full Text] [Related]
7. Wisp2/CCN5 up-regulated in the central nervous system of GM3-only mice facilitates neurite formation in Neuro2a cells via integrin-Akt signaling.
Ohkawa Y; Ohmi Y; Tajima O; Yamauchi Y; Furukawa K; Furukawa K
Biochem Biophys Res Commun; 2011 Aug; 411(3):483-9. PubMed ID: 21723256
[TBL] [Abstract][Full Text] [Related]
8. IRE1 inhibition affects the expression of insulin-like growth factor binding protein genes and modifies its sensitivity to glucose deprivation in U87 glioma cells.
Minchenko DO; Kharkova AP; Tsymbal DO; Karbovskyi LL; Minchenko OH
Endocr Regul; 2015 Oct; 49(4):185-97. PubMed ID: 26494037
[TBL] [Abstract][Full Text] [Related]
9. CCN5 is a growth arrest-specific gene that regulates smooth muscle cell proliferation and motility.
Lake AC; Bialik A; Walsh K; Castellot JJ
Am J Pathol; 2003 Jan; 162(1):219-31. PubMed ID: 12507905
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Effects of CCN5/WISP2 Gene Deficiency and Transgenic Overexpression in Mice.
Alami T; Liu JL
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948212
[TBL] [Abstract][Full Text] [Related]
11. CCN5 attenuates profibrotic phenotypes of fibroblasts through the Smad6-CCN2 pathway: Potential role in epidural fibrosis.
Xu H; Liu C; Sun Z; Guo X; Zhang Y; Liu M; Li P
Int J Mol Med; 2015 Jul; 36(1):123-9. PubMed ID: 25901787
[TBL] [Abstract][Full Text] [Related]
12. WISP-2/CCN5 is involved as a novel signaling intermediate in phorbol ester-protein kinase Calpha-mediated breast tumor cell proliferation.
Sengupta K; Banerjee S; Dhar K; Saxena NK; Mehta S; Campbell DR; Banerjee SK
Biochemistry; 2006 Sep; 45(35):10698-709. PubMed ID: 16939222
[TBL] [Abstract][Full Text] [Related]
13. CCN5 Reduces Ligamentum Flavum Hypertrophy by Modulating the TGF-β Pathway.
Ye S; Kwon WK; Bae T; Kim S; Lee JB; Cho TH; Park JY; Kim K; Hur JK; Hur JW
J Orthop Res; 2019 Dec; 37(12):2634-2644. PubMed ID: 31334871
[TBL] [Abstract][Full Text] [Related]
14. WISP2 promotes cell proliferation via targeting ERK and YAP in ovarian cancer cells.
Shi ZQ; Chen ZY; Han Y; Zhu HY; Lyu MD; Zhang H; Zhang Y; Yang LQ; Pan WW
J Ovarian Res; 2020 Jul; 13(1):85. PubMed ID: 32711570
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth.
Das A; Dhar K; Maity G; Sarkar S; Ghosh A; Haque I; Dhar G; Banerjee S; Banerjee SK
Sci Rep; 2017 Apr; 7(1):1220. PubMed ID: 28450698
[TBL] [Abstract][Full Text] [Related]
16. Matricellular Protein CCN5 Reverses Established Cardiac Fibrosis.
Jeong D; Lee MA; Li Y; Yang DK; Kho C; Oh JG; Hong G; Lee A; Song MH; LaRocca TJ; Chen J; Liang L; Mitsuyama S; D'Escamard V; Kovacic JC; Kwak TH; Hajjar RJ; Park WJ
J Am Coll Cardiol; 2016 Apr; 67(13):1556-1568. PubMed ID: 27150688
[TBL] [Abstract][Full Text] [Related]
17. CCN5 activation by free or encapsulated EGCG is required to render triple-negative breast cancer cell viability and tumor progression.
Das A; Haque I; Ray P; Ghosh A; Dutta D; Quadir M; De A; Gunewardena S; Chatterjee I; Banerjee S; Weir S; Banerjee SK
Pharmacol Res Perspect; 2021 Apr; 9(2):e00753. PubMed ID: 33745223
[TBL] [Abstract][Full Text] [Related]
18. The carboxyl-terminal TSP1-homology domain is the biologically active effector peptide of matricellular protein CCN5 that counteracts profibrotic CCN2.
Zolfaghari S; Kaasbøll OJ; Monsen VT; Sredic B; Hagelin EMV; Attramadal H
J Biol Chem; 2023 Jan; 299(1):102803. PubMed ID: 36529291
[TBL] [Abstract][Full Text] [Related]
19. Wnt1 inducible signalling pathway protein-2 (WISP‑2/CCN5): roles and regulation in human cancers (review).
Ji J; Jia S; Ji K; Jiang WG
Oncol Rep; 2014 Feb; 31(2):533-9. PubMed ID: 24337439
[TBL] [Abstract][Full Text] [Related]
20. [Effects of CCN5 overexpression on the expression of alpha-SMA and collagen I in hepatic stellate cells and its mechanism].
Zhang CY; Xie X; Gao DS; Zhang CX
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Sep; 29(5):411-5. PubMed ID: 24386815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
